NM_000395.3:c.1807C>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000395.3(CSF2RB):​c.1807C>A​(p.Pro603Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.039 in 1,572,632 control chromosomes in the GnomAD database, including 1,340 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.030 ( 101 hom., cov: 32)
Exomes 𝑓: 0.040 ( 1239 hom. )

Consequence

CSF2RB
NM_000395.3 missense

Scores

10
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.00

Publications

15 publications found
Variant links:
Genes affected
CSF2RB (HGNC:2436): (colony stimulating factor 2 receptor subunit beta) The protein encoded by this gene is the common beta chain of the high affinity receptor for IL-3, IL-5 and CSF. Defects in this gene have been reported to be associated with protein alveolar proteinosis (PAP). [provided by RefSeq, Jul 2008]
CSF2RB Gene-Disease associations (from GenCC):
  • surfactant metabolism dysfunction, pulmonary, 5
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary pulmonary alveolar proteinosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0054210126).
BP6
Variant 22-36937615-C-A is Benign according to our data. Variant chr22-36937615-C-A is described in ClinVar as Benign. ClinVar VariationId is 504754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0301 (4587/152284) while in subpopulation NFE AF = 0.0446 (3034/68000). AF 95% confidence interval is 0.0433. There are 101 homozygotes in GnomAd4. There are 2260 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 101 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CSF2RBNM_000395.3 linkc.1807C>A p.Pro603Thr missense_variant Exon 14 of 14 ENST00000403662.8 NP_000386.1 P32927-1Q6NSJ8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CSF2RBENST00000403662.8 linkc.1807C>A p.Pro603Thr missense_variant Exon 14 of 14 5 NM_000395.3 ENSP00000384053.3 P32927-1
CSF2RBENST00000406230.5 linkc.1825C>A p.Pro609Thr missense_variant Exon 13 of 13 1 ENSP00000385271.1 P32927-2

Frequencies

GnomAD3 genomes
AF:
0.0301
AC:
4586
AN:
152166
Hom.:
101
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00692
Gnomad AMI
AF:
0.0603
Gnomad AMR
AF:
0.0236
Gnomad ASJ
AF:
0.0222
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0280
Gnomad FIN
AF:
0.0529
Gnomad MID
AF:
0.0601
Gnomad NFE
AF:
0.0446
Gnomad OTH
AF:
0.0258
GnomAD2 exomes
AF:
0.0318
AC:
5679
AN:
178744
AF XY:
0.0334
show subpopulations
Gnomad AFR exome
AF:
0.00559
Gnomad AMR exome
AF:
0.0136
Gnomad ASJ exome
AF:
0.0227
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0529
Gnomad NFE exome
AF:
0.0445
Gnomad OTH exome
AF:
0.0322
GnomAD4 exome
AF:
0.0399
AC:
56717
AN:
1420348
Hom.:
1239
Cov.:
35
AF XY:
0.0399
AC XY:
28009
AN XY:
702762
show subpopulations
African (AFR)
AF:
0.00563
AC:
183
AN:
32478
American (AMR)
AF:
0.0140
AC:
529
AN:
37902
Ashkenazi Jewish (ASJ)
AF:
0.0238
AC:
603
AN:
25322
East Asian (EAS)
AF:
0.0000536
AC:
2
AN:
37280
South Asian (SAS)
AF:
0.0284
AC:
2335
AN:
82310
European-Finnish (FIN)
AF:
0.0566
AC:
2822
AN:
49878
Middle Eastern (MID)
AF:
0.0392
AC:
224
AN:
5712
European-Non Finnish (NFE)
AF:
0.0440
AC:
47977
AN:
1090662
Other (OTH)
AF:
0.0347
AC:
2042
AN:
58804
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
3564
7129
10693
14258
17822
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1794
3588
5382
7176
8970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0301
AC:
4587
AN:
152284
Hom.:
101
Cov.:
32
AF XY:
0.0304
AC XY:
2260
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.00690
AC:
287
AN:
41568
American (AMR)
AF:
0.0236
AC:
361
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0222
AC:
77
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.0284
AC:
137
AN:
4826
European-Finnish (FIN)
AF:
0.0529
AC:
562
AN:
10620
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0446
AC:
3034
AN:
68000
Other (OTH)
AF:
0.0255
AC:
54
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
225
450
674
899
1124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0390
Hom.:
380
Bravo
AF:
0.0265
TwinsUK
AF:
0.0405
AC:
150
ALSPAC
AF:
0.0433
AC:
167
ESP6500AA
AF:
0.00516
AC:
22
ESP6500EA
AF:
0.0364
AC:
305
ExAC
AF:
0.0255
AC:
3001
Asia WGS
AF:
0.00808
AC:
28
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 21205713, 20981092, 9410898, 27884173) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 26, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Pro603Thr in exon 14 of CSF2RB: This variant is not expected to have clinical significance because it has been identified in 3.6% (305/8368) of European Ameri can chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington. edu/EVS/; dbSNP rs1801122). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Uncertain
0.010
CADD
Benign
16
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.58
D;T;.
Eigen
Uncertain
0.47
Eigen_PC
Uncertain
0.40
FATHMM_MKL
Benign
0.74
D
LIST_S2
Benign
0.78
T;T;T
MetaRNN
Benign
0.0054
T;T;T
MetaSVM
Uncertain
0.42
D
MutationAssessor
Benign
1.9
L;.;.
PhyloP100
1.0
PrimateAI
Benign
0.43
T
PROVEAN
Uncertain
-3.7
D;D;D
REVEL
Uncertain
0.57
Sift
Uncertain
0.0070
D;D;D
Sift4G
Uncertain
0.0040
D;D;D
Polyphen
1.0
D;.;D
Vest4
0.064
MPC
0.50
ClinPred
0.011
T
GERP RS
5.4
Varity_R
0.19
gMVP
0.34
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1801122; hg19: chr22-37333657; API